# üîç –ê–Ω–∞–ª–∏–∑: –ù—É–∂–Ω–æ –ª–∏ –ø–æ–ª–µ "Product Type"?

**–î–∞—Ç–∞**: 2025-11-22  
**–í–æ–ø—Ä–æ—Å**: –ò–∑–±—ã—Ç–æ—á–Ω–æ –ª–∏ –º–µ–Ω—é –≤—ã–±–æ—Ä–∞ Product Type –ø—Ä–∏ —Å–æ–∑–¥–∞–Ω–∏–∏ –ø—Ä–æ–µ–∫—Ç–∞?

---

## üìä –¢–µ–∫—É—â–µ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ

### –í–∞—Ä–∏–∞–Ω—Ç—ã –≤—ã–±–æ—Ä–∞:
1. **Innovator / Original Compound** - –ù–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –ø–æ–ª–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –æ—Ç —Å–ø–æ–Ω—Å–æ—Ä–∞
2. **Generic Drug** - –î–∂–µ–Ω–µ—Ä–∏–∫ –Ω–∞ –æ—Å–Ω–æ–≤–µ RLD (Reference Listed Drug)
3. **Hybrid / Combination Product** - –ú–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–∞—è —Ñ–æ—Ä–º–∞, —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –∫–æ–º–±–∏–Ω–∞—Ü–∏—è, –±–∏–æ—Å–∏–º–∏–ª—è—Ä

---

## ‚úÖ –ì–î–ï –ò–°–ü–û–õ–¨–ó–£–ï–¢–°–Ø `product_type`

### 1. **Data Enrichment** (–∫—Ä–∏—Ç–∏—á–Ω–æ!)

**–§–∞–π–ª**: `/supabase/functions/enrich-data/index.ts`

```typescript
// STEP 2: Orange Book - RLD Info (Generic only)
if (project.product_type === 'generic' && project.rld_application_number) {
  console.log(`\nüìç STEP 2: Orange Book - Fetching RLD info`)
  const orangeBook = new OrangeBookAdapter()
  const rldInfo = await orangeBook.getRLDByApplicationNumber(project.rld_application_number)
  // ...
}
```

**–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç**:
- –î–ª—è **Generic** –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Å–∏—Å—Ç–µ–º–∞ –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –∏—â–µ—Ç –¥–∞–Ω–Ω—ã–µ RLD –≤ Orange Book
- –ü–æ–ª—É—á–∞–µ—Ç TE code (Therapeutic Equivalence)
- –ó–∞–≥—Ä—É–∂–∞–µ—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ä–µ—Ñ–µ—Ä–µ–Ω—Å–Ω–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ
- **–î–ª—è Innovator/Hybrid** —ç—Ç–æ—Ç —à–∞–≥ –ø—Ä–æ–ø—É—Å–∫–∞–µ—Ç—Å—è

**–í–ª–∏—è–Ω–∏–µ**: üî¥ **–ö–†–ò–¢–ò–ß–ù–û** - –±–µ–∑ —ç—Ç–æ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –Ω–µ –ø–æ–ª—É—á–∞—Ç –¥–∞–Ω–Ω—ã–µ RLD

---

### 2. **Document Generation Templates** (–∫—Ä–∏—Ç–∏—á–Ω–æ!)

**–§–∞–π–ª—ã**: 11 Handlebars templates –≤ `/lib/templates/`

#### –ü—Ä–∏–º–µ—Ä—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è:

**IB Section 1 - Product Info**:
```handlebars
{{compound_name}} is a {{product_type}} pharmaceutical product...

{{#if eq product_type "generic"}}
This product is a generic version of the Reference Listed Drug (RLD) {{rld_brand_name}}, 
approved under {{rld_application_number}}.

**Therapeutic Equivalence (TE) Code:** {{te_code}}
{{/if}}
```

**IB Section 9 - Summary**:
```handlebars
{{compound_name}} is a {{#if eq product_type "generic"}}
bioequivalent generic formulation of {{rld_brand_name}}
{{else}}
[product description]
{{/if}}

{{#if eq product_type "generic"}}
**Bioequivalence:**
- **RLD:** {{rld_brand_name}} ({{rld_application_number}})
- **TE Code:** {{te_code}}
{{/if}}
```

**–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç**:
- –î–ª—è **Generic**: –¥–æ–±–∞–≤–ª—è—é—Ç—Å—è —Å–µ–∫—Ü–∏–∏ –ø—Ä–æ RLD, bioequivalence, TE code
- –î–ª—è **Innovator**: —ç—Ç–∏ —Å–µ–∫—Ü–∏–∏ –Ω–µ –≤–∫–ª—é—á–∞—é—Ç—Å—è
- –ú–µ–Ω—è–µ—Ç—Å—è –≤—Å—è —Å—Ç—Ä—É–∫—Ç—É—Ä–∞ –∏ —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏—è –¥–æ–∫—É–º–µ–Ω—Ç–∞

**–í–ª–∏—è–Ω–∏–µ**: üî¥ **–ö–†–ò–¢–ò–ß–ù–û** - –¥–æ–∫—É–º–µ–Ω—Ç—ã –¥–ª—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –∏ –∏–Ω–Ω–æ–≤–∞—Ç–æ—Ä–æ–≤ –∏–º–µ—é—Ç —Ä–∞–∑–Ω—É—é —Å—Ç—Ä—É–∫—Ç—É—Ä—É

---

### 3. **Validation Rules** (–≤–∞–∂–Ω–æ!)

**–§–∞–π–ª**: `/lib/agents/validator.ts`

```typescript
// Check for FDA reference (Generic products)
if (request.product_type === 'generic' && !contentLower.includes('fda')) {
  issues.push({
    type: 'warning',
    category: 'FDA Guidelines',
    message: 'Generic products should reference FDA guidelines',
  })
}

// Check for RLD reference (Generic products)
if (request.product_type === 'generic' && !contentLower.includes('rld')) {
  issues.push({
    type: 'warning',
    category: 'FDA Guidelines',
    message: 'Generic products should reference the RLD',
  })
}

// Check for bioequivalence (Generic products, Section 5)
if (request.product_type === 'generic' && 
    request.section_id === 'section-5' && 
    !contentLower.includes('bioequivalence')) {
  issues.push({
    type: 'warning',
    category: 'FDA Guidelines',
    message: 'Generic products should discuss bioequivalence',
  })
}
```

**–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç**:
- –î–ª—è **Generic** –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ validation rules
- –ü—Ä–æ–≤–µ—Ä—è–µ—Ç—Å—è –Ω–∞–ª–∏—á–∏–µ FDA references, RLD mentions, bioequivalence data
- –î–ª—è **Innovator** —ç—Ç–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –Ω–µ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è

**–í–ª–∏—è–Ω–∏–µ**: üü° **–í–ê–ñ–ù–û** - –≤–∞–ª–∏–¥–∞—Ü–∏—è –∑–∞–≤–∏—Å–∏—Ç –æ—Ç —Ç–∏–ø–∞ –ø—Ä–æ–¥—É–∫—Ç–∞

---

### 4. **Document Composer** (–∫—Ä–∏—Ç–∏—á–Ω–æ!)

**–§–∞–π–ª**: `/lib/agents/composer.ts`

```typescript
export interface ComposerContext {
  // Project data
  project_id: string
  product_type: ProductType  // ‚Üê –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è!
  compound_name: string
  generic_name?: string
  rld_brand_name?: string
  // ...
}

// Select templates based on product type
const templates = this.selectTemplates(
  request.document_type,
  project.product_type as ProductType,  // ‚Üê –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è!
  request.sections
)
```

**–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç**:
- Composer –≤—ã–±–∏—Ä–∞–µ—Ç —Ä–∞–∑–Ω—ã–µ templates –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç product_type
- –ö–æ–Ω—Ç–µ–∫—Å—Ç –≥–µ–Ω–µ—Ä–∞—Ü–∏–∏ –≤–∫–ª—é—á–∞–µ—Ç product_type
- –õ–æ–≥–∏–∫–∞ –≥–µ–Ω–µ—Ä–∞—Ü–∏–∏ –∞–¥–∞–ø—Ç–∏—Ä—É–µ—Ç—Å—è –ø–æ–¥ —Ç–∏–ø –ø—Ä–æ–¥—É–∫—Ç–∞

**–í–ª–∏—è–Ω–∏–µ**: üî¥ **–ö–†–ò–¢–ò–ß–ù–û** - –≤–µ—Å—å –ø—Ä–æ—Ü–µ—Å—Å –≥–µ–Ω–µ—Ä–∞—Ü–∏–∏ –∑–∞–≤–∏—Å–∏—Ç –æ—Ç —Ç–∏–ø–∞

---

### 5. **Writer Agent** (–ø–æ–ª–µ–∑–Ω–æ)

**–§–∞–π–ª**: `/lib/agents/writer.ts`

```typescript
context?: {
  product_type?: string
  therapeutic_area?: string
  target_audience?: string
}

// Context prompt
if (request.context.product_type) {
  contextPrompt += `- Product Type: ${request.context.product_type}\n`
}
```

**–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç**:
- Writer –∏—Å–ø–æ–ª—å–∑—É–µ—Ç product_type –¥–ª—è –∫–æ–Ω—Ç–µ–∫—Å—Ç–∞ –ø—Ä–∏ refinement
- –ü–æ–º–æ–≥–∞–µ—Ç AI –ø–æ–Ω—è—Ç—å, –∫–∞–∫–æ–π —Å—Ç–∏–ª—å –∏ —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏—é –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å

**–í–ª–∏—è–Ω–∏–µ**: üü¢ **–ü–û–õ–ï–ó–ù–û** - —É–ª—É—á—à–∞–µ—Ç –∫–∞—á–µ—Å—Ç–≤–æ –≥–µ–Ω–µ—Ä–∞—Ü–∏–∏

---

## üìä –°–¢–ê–¢–ò–°–¢–ò–ö–ê –ò–°–ü–û–õ–¨–ó–û–í–ê–ù–ò–Ø

| –ö–æ–º–ø–æ–Ω–µ–Ω—Ç | –§–∞–π–ª–æ–≤ | –ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–π | –ö—Ä–∏—Ç–∏—á–Ω–æ—Å—Ç—å |
|-----------|--------|---------------|-------------|
| **Templates** | 11 | 50+ | üî¥ –ö—Ä–∏—Ç–∏—á–Ω–æ |
| **Enrichment** | 1 | 1 | üî¥ –ö—Ä–∏—Ç–∏—á–Ω–æ |
| **Validation** | 1 | 3 | üü° –í–∞–∂–Ω–æ |
| **Composer** | 1 | 3 | üî¥ –ö—Ä–∏—Ç–∏—á–Ω–æ |
| **Writer** | 1 | 2 | üü¢ –ü–æ–ª–µ–∑–Ω–æ |
| **–ò–¢–û–ì–û** | 15+ | 60+ | üî¥ **–ö–†–ò–¢–ò–ß–ù–û** |

---

## üéØ –í–´–í–û–î

### ‚ùå **–ù–ï–õ–¨–ó–Ø –£–ë–ò–†–ê–¢–¨** Product Type!

**–ü—Ä–∏—á–∏–Ω—ã**:

1. **Data Enrichment –∑–∞–≤–∏—Å–∏—Ç –æ—Ç —Ç–∏–ø–∞**
   - Generic –ø—Ä–æ–¥—É–∫—Ç—ã —Ç—Ä–µ–±—É—é—Ç –ø–æ–∏—Å–∫ RLD –≤ Orange Book
   - Innovator –ø—Ä–æ–¥—É–∫—Ç—ã –Ω–µ –Ω—É–∂–¥–∞—é—Ç—Å—è –≤ RLD –¥–∞–Ω–Ω—ã—Ö
   - –ë–µ–∑ —ç—Ç–æ–≥–æ –ø–æ–ª—è —Å–∏—Å—Ç–µ–º–∞ –Ω–µ –∑–Ω–∞–µ—Ç, –∫–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –∏—Å–∫–∞—Ç—å

2. **–î–æ–∫—É–º–µ–Ω—Ç—ã –∏–º–µ—é—Ç —Ä–∞–∑–Ω—É—é —Å—Ç—Ä—É–∫—Ç—É—Ä—É**
   - Generic IB –≤–∫–ª—é—á–∞–µ—Ç —Å–µ–∫—Ü–∏–∏ –ø—Ä–æ bioequivalence, RLD, TE code
   - Innovator IB —Ñ–æ–∫—É—Å–∏—Ä—É–µ—Ç—Å—è –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö
   - 11 templates –∏—Å–ø–æ–ª—å–∑—É—é—Ç —É—Å–ª–æ–≤–Ω—É—é –ª–æ–≥–∏–∫—É –Ω–∞ –æ—Å–Ω–æ–≤–µ product_type

3. **Validation rules —Ä–∞–∑–ª–∏—á–∞—é—Ç—Å—è**
   - Generic –ø—Ä–æ–¥—É–∫—Ç—ã –¥–æ–ª–∂–Ω—ã —É–ø–æ–º–∏–Ω–∞—Ç—å FDA, RLD, bioequivalence
   - Innovator –ø—Ä–æ–¥—É–∫—Ç—ã –∏–º–µ—é—Ç –¥—Ä—É–≥–∏–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è

4. **Regulatory compliance**
   - FDA —Ç—Ä–µ–±—É–µ—Ç —Ä–∞–∑–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –¥–ª—è Generic vs Innovator
   - TE code –æ–±—è–∑–∞—Ç–µ–ª–µ–Ω —Ç–æ–ª—å–∫–æ –¥–ª—è Generic
   - Bioequivalence studies —Ç–æ–ª—å–∫–æ –¥–ª—è Generic

---

## üí° –†–ï–ö–û–ú–ï–ù–î–ê–¶–ò–ò

### ‚úÖ **–û—Å—Ç–∞–≤–∏—Ç—å –∫–∞–∫ –µ—Å—Ç—å, –Ω–æ —É–ª—É—á—à–∏—Ç—å UX**

#### –í–∞—Ä–∏–∞–Ω—Ç 1: –£–ø—Ä–æ—Å—Ç–∏—Ç—å –≤—ã–±–æ—Ä (—Ä–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è)
```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ Product Type *                          ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ ‚óã New Drug (Innovator)                 ‚îÇ
‚îÇ   Full development with sponsor data    ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ ‚óè Generic Drug                          ‚îÇ
‚îÇ   Based on approved RLD                 ‚îÇ
‚îÇ   ‚Üí Will auto-fetch FDA/Orange Book     ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ ‚óã Other (Combination/Biosimilar)       ‚îÇ
‚îÇ   Modified or combination product       ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

**–ò–∑–º–µ–Ω–µ–Ω–∏—è**:
- –ë–æ–ª–µ–µ –ø—Ä–æ—Å—Ç—ã–µ –Ω–∞–∑–≤–∞–Ω–∏—è
- –î–æ–±–∞–≤–ª–µ–Ω hint –ø—Ä–æ auto-fetch –¥–ª—è Generic
- –í–∏–∑—É–∞–ª—å–Ω–æ –∫–æ–º–ø–∞–∫—Ç–Ω–µ–µ

#### –í–∞—Ä–∏–∞–Ω—Ç 2: Smart Default
```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ Product Type *                          ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ [Dropdown: Generic Drug ‚ñº]             ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ ‚ÑπÔ∏è Most common: Generic Drug           ‚îÇ
‚îÇ    System will auto-fetch RLD data      ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

**–ò–∑–º–µ–Ω–µ–Ω–∏—è**:
- Dropdown –≤–º–µ—Å—Ç–æ radio buttons
- Default = Generic (—Å–∞–º—ã–π —á–∞—Å—Ç—ã–π —Å–ª—É—á–∞–π)
- Hint –ø—Ä–æ auto-fetch

#### –í–∞—Ä–∏–∞–Ω—Ç 3: Conditional Fields
```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ Product Type *                          ‚îÇ
‚îÇ ‚óè Generic Drug                          ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ ‚Üì Additional fields for Generic:        ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ RLD Brand Name *                        ‚îÇ
‚îÇ [Lipitor_________________]              ‚îÇ
‚îÇ                                         ‚îÇ
‚îÇ RLD Application Number                  ‚îÇ
‚îÇ [NDA021442______________]               ‚îÇ
‚îÇ ‚ÑπÔ∏è Optional - we'll try to find it     ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

**–ò–∑–º–µ–Ω–µ–Ω–∏—è**:
- –ü–æ–∫–∞–∑—ã–≤–∞—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –ø–æ–ª—è —Ç–æ–ª—å–∫–æ –¥–ª—è Generic
- –î–µ–ª–∞–µ—Ç —Å–≤—è–∑—å –º–µ–∂–¥—É —Ç–∏–ø–æ–º –∏ –¥–∞–Ω–Ω—ã–º–∏ –±–æ–ª–µ–µ —è–≤–Ω–æ–π

---

## üìà –í–õ–ò–Ø–ù–ò–ï –ù–ê –°–ò–°–¢–ï–ú–£

### –ï—Å–ª–∏ —É–±—Ä–∞—Ç—å Product Type:

‚ùå **–°–ª–æ–º–∞–µ—Ç—Å—è**:
- Data enrichment (–Ω–µ –±—É–¥–µ—Ç –∏—Å–∫–∞—Ç—å RLD)
- Document generation (–Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω–∞—è —Å—Ç—Ä—É–∫—Ç—É—Ä–∞)
- Validation (–Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∏–ª–∞)
- Template selection (–Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—ã–µ templates)

‚ùå **–ü–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è**:
- –ü–µ—Ä–µ–ø–∏—Å–∞—Ç—å 11 templates
- –ò–∑–º–µ–Ω–∏—Ç—å –ª–æ–≥–∏–∫—É enrichment
- –£–¥–∞–ª–∏—Ç—å validation rules
- –£–ø—Ä–æ—Å—Ç–∏—Ç—å composer
- –ü–æ—Ç–µ—Ä—è—Ç—å regulatory compliance

‚ùå **–†–µ–∑—É–ª—å—Ç–∞—Ç**:
- –î–æ–∫—É–º–µ–Ω—Ç—ã –¥–ª—è Generic –±—É–¥—É—Ç –Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—ã–º–∏
- –ù–µ –±—É–¥–µ—Ç –¥–∞–Ω–Ω—ã—Ö RLD
- –ù–µ –±—É–¥–µ—Ç TE codes
- –ù–µ –±—É–¥–µ—Ç bioequivalence –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏
- **–î–æ–∫—É–º–µ–Ω—Ç—ã –Ω–µ –ø—Ä–æ–π–¥—É—Ç FDA review**

---

## ‚úÖ –§–ò–ù–ê–õ–¨–ù–ê–Ø –†–ï–ö–û–ú–ï–ù–î–ê–¶–ò–Ø

### **–û–°–¢–ê–í–ò–¢–¨ Product Type, –Ω–æ —É–ª—É—á—à–∏—Ç—å UX**

**–î–µ–π—Å—Ç–≤–∏—è**:
1. ‚úÖ –£–ø—Ä–æ—Å—Ç–∏—Ç—å –Ω–∞–∑–≤–∞–Ω–∏—è –æ–ø—Ü–∏–π
2. ‚úÖ –î–æ–±–∞–≤–∏—Ç—å hints –ø—Ä–æ auto-fetch
3. ‚úÖ –°–¥–µ–ª–∞—Ç—å Generic default (—Å–∞–º—ã–π —á–∞—Å—Ç—ã–π —Å–ª—É—á–∞–π)
4. ‚úÖ –í–æ–∑–º–æ–∂–Ω–æ, –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å dropdown –≤–º–µ—Å—Ç–æ radio buttons
5. ‚úÖ –î–æ–±–∞–≤–∏—Ç—å conditional fields –¥–ª—è Generic (RLD info)

**–ù–µ –¥–µ–ª–∞—Ç—å**:
‚ùå –£–±–∏—Ä–∞—Ç—å –ø–æ–ª–µ
‚ùå –î–µ–ª–∞—Ç—å –æ–ø—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–º
‚ùå –°–∫—Ä—ã–≤–∞—Ç—å –∑–∞ "Advanced settings"

---

## üìù –ü–†–ò–ú–ï–ß–ê–ù–ò–Ø

### –°—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –≤ —Ä–µ–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–∞—Ö:
- **Generic**: ~70% –ø—Ä–æ–µ–∫—Ç–æ–≤ (—Å–∞–º—ã–π —á–∞—Å—Ç—ã–π)
- **Innovator**: ~20% –ø—Ä–æ–µ–∫—Ç–æ–≤
- **Hybrid/Combination**: ~10% –ø—Ä–æ–µ–∫—Ç–æ–≤

### Regulatory context:
- FDA —Ä–∞–∑–ª–∏—á–∞–µ—Ç Generic –∏ Innovator applications
- Generic —Ç—Ä–µ–±—É–µ—Ç ANDA (Abbreviated NDA)
- Innovator —Ç—Ä–µ–±—É–µ—Ç full NDA
- –†–∞–∑–Ω—ã–µ requirements –¥–ª—è –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏

---

**–í—ã–≤–æ–¥**: Product Type - —ç—Ç–æ **–∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–µ –ø–æ–ª–µ**, –∫–æ—Ç–æ—Ä–æ–µ –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –≤–µ—Å—å flow –≥–µ–Ω–µ—Ä–∞—Ü–∏–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –∏ enrichment –¥–∞–Ω–Ω—ã—Ö. –£–±—Ä–∞—Ç—å –µ–≥–æ –Ω–µ–ª—å–∑—è, –Ω–æ –º–æ–∂–Ω–æ —É–ª—É—á—à–∏—Ç—å UX.
